Pharmaceuticals

Anti-Inflammatory Drugs Market Forecast 2026: Where the Industry Is Headed

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the anti-inflammatory drugs market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Anti-Inflammatory Drugs Market by the end of 2030?

The anti-inflammatory drugs market size has experienced significant expansion in recent years. This market is projected to grow from $152.08 billion in 2025 to $168.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.0%. The increase observed in previous periods stems from factors such as arthritis prevalence, nsaid usage, hospital prescribing, the burden of autoimmune diseases, and the adoption of steroid therapy.

The anti-inflammatory drugs market size is anticipated to undergo significant expansion over the next few years, with projections indicating it will reach $252.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period is attributable to innovations in biologics, increased penetration of biosimilars, an aging population, the growing prevalence of autoimmune diseases, and the adoption of precision medicine. Noteworthy trends for the forecast period include the expanding use of biologics and biosimilars, the broadening of treatments for chronic inflammatory diseases, a shift towards more targeted anti-inflammatory therapies, an increase in topical and localized formulations, and a greater emphasis on long-term safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp

What Drivers Are Shaping Future Opportunities In The Anti-Inflammatory Drugs Market?

The growing occurrence of arthritis is anticipated to boost the expansion of the anti-inflammatory drugs market in the foreseeable future. Arthritis is defined as the inflammation of multiple joints, leading to discomfort, swelling, and rigidity that tends to intensify with advancing age. The increased incidence of arthritis largely stems from aging demographics; as individuals age, the natural deterioration of joints rises, leading to a greater probability of developing the condition. Anti-inflammatory medications assist in managing arthritis by alleviating joint inflammation and pain, thereby enabling patients to sustain improved mobility and conduct daily tasks more readily, ultimately enhancing their general well-being. For example, data from July 2024, provided by Restored CDC, a US-based nonprofit health information organization, indicated that approximately 21.2% of adults aged 18 and older in the US received an arthritis diagnosis in 2023. Consequently, the increasing prevalence of arthritis is fueling the growth of the anti-inflammatory drugs market.

Which Segments Are Gaining Traction In The Anti-Inflammatory Drugs Market?

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

What Upcoming Trends Are Likely To Define The Future Path Of The Anti-Inflammatory Drugs Market?

Leading companies in the anti-inflammatory drugs market are concentrating on developing innovative solutions, such as next-generation corticosteroid alternatives, to address the increasing need for safer, long-term anti-inflammatory treatments. These advanced corticosteroid alternatives are therapies engineered to maintain glucocorticoid anti-inflammatory effects while mitigating common adverse outcomes associated with traditional steroids, including bone loss, growth suppression, and weight gain. For instance, in October 2023, Santhera Pharmaceuticals, a Switzerland-based specialty pharmaceutical company, obtained US FDA approval for AGAMREE (vamorolone). AGAMREE is an oral dissociative steroid crafted to provide anti-inflammatory activity with reduced steroid-related side effects by selectively modulating glucocorticoid receptor pathways and stabilizing cell membranes. Compared to conventional corticosteroids such as prednisone and deflazacort, it presents a more advantageous safety profile while retaining its therapeutic benefits. It is utilized for managing chronic muscle inflammation in children aged two years and older who have Duchenne muscular dystrophy.

Who Are The Primary Competitors In The Global Anti-Inflammatory Drugs Market?

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Anti-Inflammatory Drugs Market?

North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Anti-Inflammatory Drugs Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24465&type=smp

Browse Through More Reports Similar to the Global Anti-Inflammatory Drugs Market 2026, By The Business Research Company

Rheumatology Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

Non Steroidal Anti Inflammatory Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795